Mida tähendab "Tühjenda"?
Loom ei kanna mutatsiooni. See ei arenda haigust ja ei anna seda edasi.
Koer 1. tüüpi gangliosidoos Shiba Inus (GM1-SI)
Discover the importance of the DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs, a critical genetic screening to ensure your pet’s health. GM1 gangliosidosis is a rare but severe inherited disorder affecting the nervous system, leading to progressive neurological decline. Early DNA testing helps breeders and owners identify carriers and affected dogs, preventing the spread of this debilitating condition. By using a reliable GM1 DNA test, you can make informed breeding decisions and protect future generations of Shiba Inu. Ensure your dog’s well-being with accurate genetic screening for Gangliosidosis Type 1 today. Prioritize health and longevity with this essential DNA test for Shiba Inu.
Lühend: GM1-SI
Analüüsitud mutatsioon: GLB1 c.1649delC
Pärand: Autosoomne retsessiivne
Akronüüm
GM1-SI
Täheldatud sagedus
Kliiniline raskusaste
Kliiniline klassifikatsioon
Neuroloogilised haigused
Analüüsitud mutatsioon
GLB1 c.1649delC
p.(P550Rfs*50)
p.(P550Rfs*50)
Pärimisviis
Autosoomne retsessiivne (Täielik)
Testi kokkuvõte:
The DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs helps identify carriers and affected individuals of this genetic disorder. GM1 gangliosidosis is a rare, inherited lysosomal storage disease that causes progressive neurological decline. Early detection through genetic testing allows breeders to make informed decisions to reduce the risk of passing the condition to offspring. This test is crucial for maintaining the health and longevity of the Shiba Inu breed. Responsible breeding practices rely on such DNA tests to prevent the spread of GM1 in the population.
Saadaval pakendist: Basic
See DNA test on kaasas alates meie pakist Basic — ja on ka osa pakkidest Basic, Standard, Advanced, Complete.
Vaadake DNA testipakette →Valige pakk, mis sobib teie loomade aretus- või tervisestrateegiaga kõige paremini.
Understanding Gangliosidosis Type 1 (GM1) in Shiba Inu
Gangliosidosis Type 1, commonly referred to as GM1, is a genetic disorder that affects the metabolism of certain lipids, specifically gangliosides, in the brain and nervous system of dogs. This condition is particularly noted in the Shiba Inu breed. GM1 is caused by a deficiency in the enzyme beta-galactosidase, which leads to the accumulation of gangliosides in the cells, resulting in neurological dysfunction and a range of clinical symptoms.
Clinical Symptoms of GM1
The symptoms of Gangliosidosis Type 1 typically manifest between the ages of three to six months. Affected dogs may exhibit a variety of neurological signs, including but not limited to, ataxia (loss of coordination), tremors, seizures, and a decline in cognitive functions. As the disease progresses, dogs may experience muscle weakness, difficulty walking, and a general decline in their quality of life. In severe cases, GM1 can lead to premature death, often occurring within the first few years of life.
Diagnosis of GM1
Diagnosis of Gangliosidosis Type 1 is primarily achieved through genetic testing that identifies mutations in the gene responsible for producing the beta-galactosidase enzyme. While clinical signs can suggest the presence of GM1, definitive diagnosis through a DNA test is crucial for confirming the disorder. Early detection allows for better management of the dog's health and can guide owners in making informed decisions about their pet's care.
Treatment and Management
Currently, there is no cure for Gangliosidosis Type 1, and treatment focuses on managing the symptoms and improving the quality of life for affected dogs. Supportive care may include physical therapy, pain management, and nutritional support. Regular veterinary check-ups are essential to monitor the progression of the disease and to address any arising complications.
Importance of Genetic Testing
Genetic testing for GM1 is critical for breeders and dog owners. By identifying carriers of the disease, responsible breeding practices can be implemented to reduce the incidence of GM1 in future generations. Awareness and understanding of this condition are vital in promoting the health and longevity of the Shiba Inu breed.
Testi jaoks tunnustatud tõug: 1. tüüpi gangliosidoos Shiba Inus (GM1-SI)
- Shiba Inu
🧬 Interpretation of genotypes GM1-SI
Genotüüp
Olek
🟡 N/N
Mittekandja – riskivaba
🟡 N/GM1-SI
Vedaja – riskivaba
❌ GM1-SI/GM1-SI
Mõjutatud – ohus
KKK: tõlgenduse mõistmine
Kas "kandja" on tõsine?
Ei. Loom on üldiselt terve, kuid võib mutatsiooni omale edasi anda järglased.
Mis siis, kui loom on "mõjutatud"?
Sellel on kaks muteerunud koopiat. Sõltuvalt sellest on oodata kliinilisi tunnuseid haigus. Seda ei tohiks aretada.
Miks on meeste ja naiste vahel erinevusi?
Mõned haigused on sooga seotud, mistõttu nende väljendus varieerub sõltuvalt looma sugu.
Ennusta järglasi
N/N (mittekandja)
N/GM1-SI (Kandja)
GM1-SI/GM1-SI (Mõjutatud)
DNA-testi KKK
Mida see DNA test tuvastab?
This DNA test detects the mutation associated with Gangliosidosis Type 1 In Shiba Inu (GM1-SI) in order to identify clear, carrier, or at-risk animals.
Miks testida aretuslooma?
DNA testimine aitab kasvatajatel planeerida turvalisemaid paaritusi ja vähendada mutatsiooni järglastele edasikandumise ohtu.
Mis on selle testi pärimisviis?
Selle testi jaoks teatatud pärimisrežiim on autosoomne retsessiivne.
Millist mutatsiooni selles testis analüüsitakse?
This test analyses the mutation GLB1 c.1649delC.
Kas kandjaloom on tingimata mõjutatud?
Mitte tingimata. Tõlgendamine sõltub pärimismustrist ja sellest tulenevast genotüübist.
Viited
Yamato O, Endoh D, Kobayashi A, Masuoka Y, Yonemura M, Hatakeyama A, Satoh H, Tajima M, Yamasaki M, Maede Y. A novel mutation in the gene for canine acid beta-galactosidase that causes GM1-gangliosidosis in Shiba dogs. J Inherit Metab Dis. 2002 Oct;25(6):525-6. doi: 10.1023/a:1021280007739.